Phoenix Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
3,311
+246
| +8% | +$19.2K | ﹤0.01% | 354 |
|
|
2025
Q1 | $222K | Sell |
3,065
-41,244
| -93% | -$2.99M | ﹤0.01% | 335 |
|
|
2024
Q4 | $3.28M | Sell |
44,309
-4,524
| -9% | -$335K | 0.04% | 164 |
|
|
2024
Q3 | $3.22M | Buy |
48,833
+25,104
| +106% | +$1.66M | 0.05% | 165 |
|
|
2024
Q2 | $2.19M | Buy |
23,729
+20,930
| +748% | +$1.93M | 0.03% | 178 |
|
|
2024
Q1 | $267K | Sell |
2,799
-29,534
| -91% | -$2.82M | ﹤0.01% | 344 |
|
|
2023
Q4 | $2.76M | Buy |
32,333
+4,202
| +15% | +$359K | 0.05% | 170 |
|
|
2023
Q3 | $1.95M | Buy |
28,131
+12,137
| +76% | +$842K | 0.04% | 178 |
|
|
2023
Q2 | $1.5M | Buy |
15,994
+3,357
| +27% | +$316K | 0.03% | 183 |
|
|
2023
Q1 | $1.05M | Buy |
12,637
+1,544
| +14% | +$128K | 0.02% | 181 |
|
|
2022
Q4 | $829K | Buy |
11,093
+293
| +3% | +$21.9K | 0.02% | 192 |
|
|
2022
Q3 | $907K | Buy |
10,800
+1,111
| +11% | +$93.3K | 0.02% | 199 |
|
|
2022
Q2 | $921K | Sell |
9,689
-205
| -2% | -$19.5K | 0.02% | 221 |
|
|
2022
Q1 | $1.17M | Buy |
9,894
+5,409
| +121% | +$637K | 0.02% | 245 |
|
|
2021
Q4 | $585K | Sell |
4,485
-961
| -18% | -$125K | 0.01% | 267 |
|
|
2021
Q3 | $616K | Buy |
+5,446
| New | +$616K | 0.01% | 291 |
|
|
2021
Q2 | – | Sell |
-7,010
| Closed | -$581K | – | 326 |
|
|
2021
Q1 | $581K | Buy |
7,010
+1,969
| +39% | +$163K | 0.01% | 305 |
|
|
2020
Q4 | $450K | Buy |
+5,041
| New | +$450K | 0.01% | 260 |
|